Diabetes care needs evidence based interventions to reduce risk of vascular disease

被引：9

作者：

Byrne, CD ^{[1
]}

Wild, SH

机构：

[1] Univ Southampton, Sch Med, Southampton Gen Hosp, Southampton SO16 6YD, Hants, England

[2] Univ Southampton, Sch Med, Hlth Care Res Unit, Southampton SO16 6YD, Hants, England

来源：

BRITISH MEDICAL JOURNAL | 2000年 / 320卷 / 7249期

关键词：

D O I：

10.1136/bmj.320.7249.1554

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1554 / 1555

页数：2

共 13 条

[1]

Gerstein HC, 2000, LANCET, V355, P253

[2] Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels -: Subgroup analyses in the Scandinavian simvastatin survival study [J].

Haffner, SM ;

Alexander, CM ;

Cook, TJ ;

Boccuzzi, SJ ;

Musliner, TA ;

Pedersen, TR ;

Kjekshus, J ;

Pyörälä, K .

ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (22) :2661-2667

[3] Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction [J].

Haffner, SM ;

Lehto, S ;

Rönnemaa, T ;

Pyörälä, K ;

Laakso, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) :229-234

[4] Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:: principal results of the hypertension optimal treatment (HOT) randomised trial [J].

Hansson, L ;

Zanchetti, A ;

Carruthers, SG ;

Dahlöf, B ;

Elmfeldt, D ;

Julius, S ;

Ménard, J ;

Rahn, KH ;

Wedel, H ;

Westerling, S .

LANCET, 1998, 351 (9118) :1755-1762

[5]

Joint British recommendations on prevention of coro-nary heart disease in clinical practice, 1998, HEART, V80, pS1

[6]

Meade TW, 1998, LANCET, V351, P233

[7] Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol [J].

Rubins, HB ;

Robins, SJ ;

Collins, D ;

Fye, CL ;

Anderson, JW ;

Elam, MB ;

Faas, FH ;

Linares, E ;

Schaefer, EJ ;

Schectman, G ;

Wilt, TJ ;

Wittes, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (06) :410-418

[8] The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels [J].

Sacks, FM ;

Pfeffer, MA ;

Moye, LA ;

Rouleau, JL ;

Rutherford, JD ;

Cole, TG ;

Brown, L ;

Warnica, JW ;

Arnold, JMO ;

Wun, CC ;

Davis, BR ;

Braunwald, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1001-1009

[9]

Stearne MR, 1998, BMJ-BRIT MED J, V317, P703

[10]

Tonkin A, 1998, NEW ENGL J MED, V339, P1349

← 1 2 →